545
Participants
Start Date
April 18, 2018
Primary Completion Date
April 28, 2025
Study Completion Date
December 16, 2025
Nivolumab
Specified dose on specified days
Placebo
specified dose on specified days
Local Institution - 0248, Santiago
Local Institution - 0256, Bogotá
Local Institution - 0207, Taipei
Local Institution - 0173, Taipei
Local Institution - 0175, Taoyuan District
Local Institution - 0176, Yunlin
Local Institution - 0131, Tainan City
Local Institution - 0174, Tainan City
Local Institution - 0204, Kaohsiung City
Local Institution - 0240, Auckland
Local Institution - 0033, Brussels
Local Institution - 0003, Vienna
Local Institution - 0001, Vienna
Local Institution - 0064, Brussels
Local Institution - 0254, Pilar
Local Institution - 0244, Rosario
Local Institution - 0166, Camperdown
Local Institution - 0141, Concord
Local Institution - 0239, Blacktown
Local Institution - 0068, Edegem
Local Institution - 0108, Leuven
Local Institution - 0224, Heidelberg
Local Institution - 0220, Herston
Local Institution - 0164, Adelaide
Local Institution - 0243, Gorriti
Local Institution - 0124, Nedlands
Local Institution - 0012, Graz
Local Institution - 0071, Ghent
Local Institution - 0075, New York
Local Institution - 0208, New York
Memorial Sloan Kettering Cancer Center, New York
Local Institution - 0190, Goyang-si
Local Institution - 0219, White Plains
Local Institution - 0129, Taipei
Local Institution - 0258, Berlin
Local Institution - 0169, Seongnam-si
Local Institution - 0016, Córdoba
Local Institution - 0191, Suwon
Local Institution - 0072, Donostia / San Sebastian
Local Institution - 0091, Milan
McGuire VA Medical Center, Richmond
Local Institution - 0199, Madrid
Local Institution - 0109, Madrid
Local Institution - 0052, Brest
Local Institution - 0009, Atlanta
Local Institution - 0040, Hanover
Local Institution - 0100, Pamplona
Miami VA Healthcare System, Miami
Sylvester Comprehensive Cancer Center/ UMHC, Miami
Local Institution - 0163, Tampa
Local Institution - 0043, Montpellier
Local Institution - 0212, Rennes
Local Institution - 0103, Padua
Local Institution - 0081, Anniston
Local Institution - 0013, Grenoble
Local Institution - 0102, Bologna
Local Institution - 0130, Taichung
Local Institution - 0140, Taichung
Local Institution - 0028, Seville
Local Institution, Modena
Local Institution - 0177, Daegu
Local Institution - 0044, Saint-Priest-en-Jarez
MetroHealth Medical Center, Cleveland
Local Institution - 0026, Essen
Local Institution - 0082, Valencia
Local Institution - 0104, Meldola
University of Michigan, Ann Arbor
Local Institution - 0097, Zaragoza
Local Institution - 0077, Florence
Local Institution - 0188, Gyeongsangnam-do
Local Institution - 0050, Cologne
Local Institution - 0098, Reims
Local Institution - 0024, Aachen
Local Institution - 0020, Bonn
Local Institution - 0011, Vandœuvre-lès-Nancy
Local Institution - 0048, Mainz
Minnesota Oncology Hematology, P.A., Minneapolis
Local Institution - 0178, Jeollanam-do
Local Institution - 0222, Lille
Local Institution - 0093, Frankfurt am Main
CHU Estaing, Clermont-Ferrand
Local Institution - 0209, St Louis
Local Institution - 0121, Monterrey
Local Institution - 0264, Monterrey
Local Institution - 0025, Westwood
Local Institution - 0019, Homburg
Universitatsmedizin Mannheim, Mannheim
Local Institution - 0051, Lyon
Local Institution - 0086, New Orleans
Local Institution - 0008, Tübingen
Texas Oncology Sammons Cancer Center, Dallas
Local Institution - 0156, Dallas
Local Institution - 0273, Tyler
Local Institution - 0226, San Luis Potosí City
Local Institution - 0272, Austin
Local Institution - 0235, Aurora
Azienda Ospedaliera Specialistica dei Colli Monaldi-Cotugno-CTO, Napoli
Local Institution - 0119, Napoli
Local Institution - 0096, München
Mayo Clinic in Arizona - Phoenix, Phoenix
Arizona Oncology Associates, PC - HOPE, Tucson
Local Institution, Poitiers
Local Institution - 0135, Los Angeles
Local Institution - 0046, Clichy
Local Institution - 0057, Bobigny
Local Institution - 0061, Créteil
Local Institution - 0085, San Francisco
Local Institution - 0088, Palo Alto
Local Institution - 0054, Villejuif
Local Institution, Würzburg
Local Institution - 0206, Portland
Local Institution - 0154, Seattle
Local Institution - 0136, Messina
Local Institution - 0230, Moscow
Local Institution - 0042, Singapore
Arkhangelsk Clinical Oncological Dispensary, Arkhangelsk
Local Institution - 0067, Singapore
Local Institution, Leningrad Region
Local Institution - 0032, Saint Petersburg
Local Institution - 0074, Craiova
Local Institution - 0070, Timișoara
Local Institution - 0039, Singapore
Local Institution - 0232, Cluj-Napoca
Local Institution, Brasov
Local Institution - 0242, Constanța
Local Institution - 0120, Hong Kong
Local Institution - 0196, Chuo-ku
Local Institution - 0215, Bunkyo-ku
Local Institution - 0210, Musashino-shi
Local Institution - 0247, Viña del Mar
Local Institution - 0187, Chiba
Local Institution - 0183, Kashiwa-shi
Local Institution - 0203, Osaka
Local Institution - 0198, Osaka
Local Institution, Ōsaka-sayama
Local Institution - 0216, Nishinomiya-shi
Local Institution - 0246, Santiago
Local Institution - 0201, Kurume-shi
Local Institution - 0245, Santiago
Local Institution - 0202, Kumamoto
Local Institution - 0180, Kanazawa
Local Institution - 0090, Belo Horizonte
Local Institution - 0275, Barretos
Local Institution - 0237, Cerqueira César
Local Institution, São José do Rio Preto
Local Institution, São Paulo
Local Institution - 0023, São Paulo
Local Institution - 0236, São Paulo
Local Institution, Calgary
Local Institution - 0116, Edmonton
Local Institution - 0037, Nice
Local Institution, Leipzig
Local Institution - 0036, Magdeburg
Local Institution - 0076, Hong Kong
Local Institution - 0134, Monserrato
Fondazione Policlinico Gemelli - Universita Cattolica del Sacro Cuore, Rome
Local Institution - 0184, Sapporo
Local Institution - 0200, Sapporo
Local Institution - 0257, Morioka
Local Institution - 0214, Suita-shi
Local Institution - 0185, Tokushima
Local Institution - 0182, Mitaka-shi
Local Institution - 0186, Shinjuku-ku
Local Institution - 0179, Hiroshima
Local Institution - 0197, Kanagawa
Local Institution - 0148, Cuauhtémoc
Local Institution - 0263, Maastricht
Local Institution - 0260, Utrecht
Local Institution - 0231, San Juan
Local Institution - 0078, Bucharest
Local Institution - 0127, Seoul
Local Institution - 0128, Seoul
Local Institution - 0168, Seoul
Local Institution - 0167, Seoul
Local Institution - 0195, Seoul
Local Institution - 0189, Seoul
Local Institution - 0069, Barcelona
Local Institution - 0031, Barcelona
Local Institution - 0010, Sabadell (Barcelona)
Local Institution - 0111, London
Local Institution - 0092, London
Local Institution - 0153, London
Local Institution - 0114, Manchester
Local Institution - 0142, Metropolitan Borough of Wirral
Lead Sponsor
Collaborators (1)
Ono Pharmaceutical Co. Ltd
INDUSTRY
Bristol-Myers Squibb
INDUSTRY